Valid number
Dropdown
Select your product of interest

Thank you! Your request has been received.

A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+

Featured

EnChannel Medical Acquires Acutus Medical's AcQMap™ Electrophysiology Assets

EnChannel Medical announced the acquisition of Acutus Medical's AcQMap™ High Resolution Imaging and Mapping platform assets. This acquisition strength...

July 2, 2025

May 2024

EnChannel Medical Acquires Acutus Medical's AcQMap™ Electrophysiology Assets
EnChannel Medical announced the acquisition of Acutus Medical's AcQMap™ High Resolution Imaging and Mapping platform assets. This acquisition strength...
July 2, 2025
Biofrontera Inc. Acquires US Rights to Ameluz® and RhodoLED®, Secures $11 Million Investment
Biofrontera Inc. announced the acquisition of all US assets related to Ameluz® and RhodoLED®, including the NDA and associated patents, from Biofronte...
July 1, 2025
23andMe Sold to TTAM Research Institute for $305 Million
23andMe, a genetics-led consumer healthcare company, has received court approval for the sale of substantially all of its assets to TTAM Research Inst...
June 30, 2025
Fujirebio Acquires Plasma Services Group, Strengthening its Biomaterials Supply
Fujirebio Diagnostics, a subsidiary of Fujirebio Holdings, Inc., has acquired Plasma Services Group, Inc., a provider of high-quality biological mater...
June 23, 2025
RyboDyn Joins Lilly Gateway Labs to Advance Next-Gen Immunotherapies
RyboDyn, a biotechnology company developing first-in-class immunotherapies targeting the 'dark proteome' (previously uncharacterized proteins), has be...
June 19, 2025
Pierre Fabre Laboratories Acquires Worldwide Rights for PFL-721 and PFL-241, Expanding its Oncology Portfolio
Pierre Fabre Laboratories announced the acquisition of worldwide rights for PFL-721 and PFL-241, mutant-specific EGFR inhibitors, from Antares Therape...
June 16, 2025
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
Medtronic plc announced that its planned new diabetes company, resulting from an intended separation, will be named MiniMed. This name honors the com...
June 13, 2025
BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition
BioNTech, a global immunotherapy company, announced its intent to acquire CureVac, a clinical-stage biotech company focused on mRNA-based therapies, i...
June 12, 2025
Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease
Quell Therapeutics announced that AstraZeneca has exercised its option to license a lead Treg cell therapy candidate from their joint Inflammatory Bow...
June 10, 2025

April 2024

Sanofi Acquires Vigil Neuroscience to Expand Alzheimer's Disease Pipeline
Sanofi announced its acquisition of Vigil Neuroscience, a clinical-stage biotechnology company focused on neurodegenerative diseases. This acquisitio...
May 22, 2025
CRISPR and Sirius Therapeutics Partner to Develop siRNA Therapies for Thromboembolic Disorders
CRISPR Therapeutics and Sirius Therapeutics announced a multi-target collaboration to co-develop and co-commercialize SRSD107, a long-acting siRNA the...
May 20, 2025
Carlyle and SK Capital Complete Acquisition of bluebird bio
bluebird bio, Inc. announced that it has received all necessary regulatory approvals for its acquisition by Carlyle and SK Capital. The merger is exp...
May 6, 2025

Latest Merger & Acquisitions

EnChannel Medical Acquires Acutus Medical's AcQMap™ Electrophysiology Assets
July 2, 2025
Biofrontera Inc. Acquires US Rights to Ameluz® and RhodoLED®, Secures $11 Million Investment
July 1, 2025
23andMe Sold to TTAM Research Institute for $305 Million
June 30, 2025
Fujirebio Acquires Plasma Services Group, Strengthening its Biomaterials Supply
June 23, 2025
RyboDyn Joins Lilly Gateway Labs to Advance Next-Gen Immunotherapies
June 19, 2025
Pierre Fabre Laboratories Acquires Worldwide Rights for PFL-721 and PFL-241, Expanding its Oncology Portfolio
June 16, 2025
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
June 13, 2025
BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition
June 12, 2025
Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease
June 10, 2025
Sanofi Acquires Vigil Neuroscience to Expand Alzheimer's Disease Pipeline
May 22, 2025
CRISPR and Sirius Therapeutics Partner to Develop siRNA Therapies for Thromboembolic Disorders
May 20, 2025
Carlyle and SK Capital Complete Acquisition of bluebird bio
May 6, 2025
Repare Therapeutics Out-Licenses Discovery Platforms to DCx Biotherapeutics
May 2, 2025

Empowering Life Sciences with
Advanced AI Solutions.

Book A Demo
HomeKnolsightsContact UsPricing
One Research Ct, Suite 450 Rockville, MD, 20850
info@pienomial.com
+91 9876543210
Copyright © 2025. All rights reserved
AboutTerms of ServicePrivacy Policy
Home/KnloSights/Mregers And Acquisitions